Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Mayne Pharma International Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (62)
Cancellation by sponsor (37)
Australian Public Assessment Report (AusPAR) (5)
Prescription medicine registration (5)
Prescription medicine decision summary (1)
Prescription medicine evaluation (1)

Date

2026 (3)
2025 (5)
2024 (3)
2023 (14)
2022 (11)
2021 (5)
2020 (9)
2019 (4)
2018 (13)
2017 (7)
2015 (2)
2014 (3)
2013 (3)
2012 (4)
2010 (1)
2009 (1)
2007 (1)
2004 (2)
2002 (1)
1999 (1)
1996 (6)
1994 (3)
1991 (9)

Search

Sponsor content

111 result(s) found, displaying 61 to 70

KAPANOL (Mayne Pharma International Pty Ltd)

6 February 2019

Prescription medicine registration

Active ingredients: morphine sulfate pentahydrate.
AusPAR: Fosfomycin trometamol

12 November 2018

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Fosfomycin trometamol
MAYNE PHARMA OXYCODONE IR oxycodone hydrochloride 5 mg tablet blister pack (225335)

16 June 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MAYNE PHARMA OXYCODONE IR oxycodone hydrochloride 5 mg tablet blister pack.
DORYX 100 doxycycline 100mg (as hydrochloride) capsule blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Mayne Pharma International Pty Ltd
DORYX 50 doxycycline 50mg (as hydrochloride) capsule blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Mayne Pharma International Pty Ltd
MAYNE PHARMA DOXYCYCLINE doxycycline (as hydrochloride) 100mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Mayne Pharma International Pty Ltd
MAYNE PHARMA DOXYCYCLINE doxycycline (as hydrochloride) 50mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Mayne Pharma International Pty Ltd
ERYC erythromycin 250mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Mayne Pharma International Pty Ltd
MAYNE PHARMA ERYTHROMYCIN erthromycin 250mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Mayne Pharma International Pty Ltd
Doryx (doxycycline) 200mg tablet bottle (233175)

28 January 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Doryx (doxycycline) 200mg tablet bottle.

Pages

First page
Previous page
…
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Page 10
Page 11
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.